250 related articles for article (PubMed ID: 38183616)
1. Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
Kimball AB; Kirby J; Ingram JR; Tran T; Pansar I; Ciaravino V; Willems D; Lewis-Mikhael AM; Tongbram V; Garg A
Dermatol Ther (Heidelb); 2024 Jan; 14(1):83-98. PubMed ID: 38183616
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
[TBL] [Abstract][Full Text] [Related]
4. Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice.
Kimball AB; Crowley JJ; Papp K; Calimlim B; Duan Y; Fleischer AB; Sobell J
J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1302-1308. PubMed ID: 31800124
[TBL] [Abstract][Full Text] [Related]
5. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
[TBL] [Abstract][Full Text] [Related]
6. Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab.
Gulliver W; Alavi A; Wiseman MC; Gooderham MJ; Rao J; Shayesteh Alam M; Papp KA; Desjardins O; Jean C
J Cutan Med Surg; 2022; 26(4):361-370. PubMed ID: 35322692
[TBL] [Abstract][Full Text] [Related]
7. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
8. Interventions for hidradenitis suppurativa.
Ingram JR; Woo PN; Chua SL; Ormerod AD; Desai N; Kai AC; Hood K; Burton T; Kerdel F; Garner SE; Piguet V
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010081. PubMed ID: 26443004
[TBL] [Abstract][Full Text] [Related]
9. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
[TBL] [Abstract][Full Text] [Related]
10. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
[TBL] [Abstract][Full Text] [Related]
11. Quality of Life in Hidradenitis Suppurativa: An Update.
Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Sampogna F; Marron SE; Zemskov SV; Abeni D; Tzellos T; Szepietowski JC; Zouboulis CC
Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34204126
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
[TBL] [Abstract][Full Text] [Related]
13. Association of Resilience With Depression and Health-Related Quality of Life for Patients With Hidradenitis Suppurativa.
Kirby JS; Butt M; Esmann S; Jemec GBE
JAMA Dermatol; 2017 Dec; 153(12):1263-1269. PubMed ID: 29117300
[TBL] [Abstract][Full Text] [Related]
14. Profound consequences of hidradenitis suppurativa: a review.
Matusiak Ł
Br J Dermatol; 2020 Dec; 183(6):e171-e177. PubMed ID: 29744872
[TBL] [Abstract][Full Text] [Related]
15. Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa.
Hamzavi IH; Sundaram M; Nicholson C; Zivkovic M; Parks-Miller A; Lee J; Yi J; Gu Y; Okun MM; Ganguli A; Arikian SR
J Am Acad Dermatol; 2017 Dec; 77(6):1038-1046. PubMed ID: 28917381
[TBL] [Abstract][Full Text] [Related]
16. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
17. Patients with Hidradenitis Suppurativa Suffer from Low Health-Related Quality of Life as Measured by the Generic 15D Instrument.
Hirvonen MJ; Pasternack R; Lipitsä T; Vihervaara A; Harvima R; Ranta M; Sintonen H; Huilaja L
Skin Appendage Disord; 2022 May; 8(3):221-227. PubMed ID: 35702276
[TBL] [Abstract][Full Text] [Related]
18. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
Rivera-Díaz R; Pozo T; Alfageme F; Díaz Ley B; Osorio GF; Chico R; Vilarrasa E; Silvente C; Ciudad Blanco C; Romaní J; Martorell A; Fernández P; Romero Ferreiro C; Molina Leyva A
Actas Dermosifiliogr; 2023 Oct; 114(9):T755-T762. PubMed ID: 37479135
[TBL] [Abstract][Full Text] [Related]
19. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
Rivera-Díaz R; Pozo T; Alfageme F; Díaz Ley B; Osorio GF; Chico R; Vilarrasa E; Silvente C; Ciudad Blanco C; Romaní J; Martorell A; Fernández P; Romero Ferreiro C; Molina Leyva A
Actas Dermosifiliogr; 2023 Oct; 114(9):755-762. PubMed ID: 37331620
[TBL] [Abstract][Full Text] [Related]
20. The burden of non-alcoholic steatohepatitis: A systematic review of health-related quality of life and patient-reported outcomes.
Younossi Z; Aggarwal P; Shrestha I; Fernandes J; Johansen P; Augusto M; Nair S
JHEP Rep; 2022 Sep; 4(9):100525. PubMed ID: 36039144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
